Does INSULIN GLARGINE-YFGN Cause Device occlusion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Device occlusion have been filed in association with INSULIN GLARGINE-YFGN. This represents 0.3% of all adverse event reports for INSULIN GLARGINE-YFGN.
5
Reports of Device occlusion with INSULIN GLARGINE-YFGN
0.3%
of all INSULIN GLARGINE-YFGN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Device occlusion From INSULIN GLARGINE-YFGN?
Of the 5 reports.
Is Device occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE-YFGN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE-YFGN Cause?
Device mechanical issue (853)
Product quality issue (426)
Device issue (279)
Device delivery system issue (236)
Device defective (215)
Product storage error (212)
Wrong technique in product usage process (181)
Device breakage (164)
Incorrect dose administered (152)
Blood glucose increased (115)
What Other Drugs Cause Device occlusion?
PEGFILGRASTIM (3,239)
CARBIDOPA\LEVODOPA (1,464)
SOMATROPIN (823)
LEUPROLIDE (786)
EPOPROSTENOL (580)
TREPROSTINIL (458)
ALBUTEROL (431)
MEDROXYPROGESTERONE (284)
BACLOFEN (254)
LEVODOPA (224)
Which INSULIN GLARGINE-YFGN Alternatives Have Lower Device occlusion Risk?
INSULIN GLARGINE-YFGN vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE-YFGN vs INSULIN GLULISINE
INSULIN GLARGINE-YFGN vs INSULIN HUMAN
INSULIN GLARGINE-YFGN vs INSULIN LISPRO
INSULIN GLARGINE-YFGN vs INSULIN LISPRO-AABC